More on SVRA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $6.16 |
|
|||
| Open | $6.13 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $6.29 | ||||
| Day Low | $6.00 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 1,511,931 | ||||
- Palvella Therapeutics adds Matt Pauls to its board of directors
- Form 4 Savara Inc For: Jun 22 Filed by: Lowrance David L
- Form 144 Savara Inc Filed by: Lowrance David L
- Savara Announces New Employment Inducement Grant
- Form 8-K Savara Inc For: Jun 04
- Savara names Robert Lutz as chief operating and financial officer
- Savara Announces Chief Financial and Administrative Officer Transition
- Savara Announces Participation in the 2026 Jefferies Global Healthcare Conference
- Savara presents biomarker data from phase 3 trial at ATS conference
- Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thor
Entities mentioned with SVRA
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Show More...
